Ocera Therapeutics, Inc. Accrued Liabilities, Current
Ocera Therapeutics, Inc. had Accrued Liabilities, Current of $2.69 million as of 2017-09-30, per its 10-Q filed 2017-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2017-11-14
- 2017-09-30: Accrued Liabilities, Current $2.69M.
- 2017-06-30: Accrued Liabilities, Current $3.26M.
- 2017-03-31: Accrued Liabilities, Current $2.69M.
- 2016-12-31: Accrued Liabilities, Current $2.84M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2017-09-30 | $2.69M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $3.26M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $2.69M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $2.84M 10-Q · filed 2017-11-14 | |
| 2016-09-30 | $3.25M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $3.53M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $3.63M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $3.13M 10-K · filed 2017-03-14 | |
| 2015-09-30 | $2.50M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $2.03M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $1.96M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $1.97M 10-K · filed 2016-03-11 | |
| 2014-09-30 | $1.91M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $1.90M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $1.00M 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $1.90M 10-K · filed 2015-03-13 | |
| 2013-09-30 | $2.10M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $586.00K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $659.00K 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $280.00K 10-K · filed 2014-03-18 | $840.00K 10-K · filed 2013-03-28 |
| 2012-09-30 | $1.89M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $2.07M 10-Q · filed 2012-08-10 | |
| 2012-03-31 | $2.56M 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $1.55M 10-K · filed 2013-03-28 | |
| 2011-09-30 | $1.33M 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $1.56M 10-Q · filed 2011-08-11 | |
| 2010-12-31 | $1.17M 10-K · filed 2012-02-29 |